Skip to main content
SpringerLink
Log in

Monoklonale Antikörper für die Therapie des metastasierten Melanoms

Monoclonal antibody in the therapy of metastatic melanoma

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Hersh EM, O’Day SJ, Powderly J et al (2010) A phase II multicenter study of ipilimumb with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma. Invest New Drugs [Epub ahead of print]

  2. Hodi FS, Steven J, O’Day SJ et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723

    Article  PubMed  CAS  Google Scholar 

  3. Lawrence D, Hamid O, McDermott D et al (2010) Phase II trial of ipilimumab monotherapy in melanoma patients with brain metastasis. ASCO Annual Meeting 2010, Abstract 8523

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Klinikum rechts der Isar, TU München, Biedersteiner Straße 29, 80802, München, Deutschland

    J. Ring & R. Hein

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. J. Ring
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Hein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Ring.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ring, J., Hein, R. & Nitschmann, S. Monoklonale Antikörper für die Therapie des metastasierten Melanoms. Internist 52, 902–903 (2011). https://doi.org/10.1007/s00108-011-2885-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-011-2885-5

Search

Navigation